Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Cell And Gene Therapy Contract Research Organization Market Poised To Hit $12.36 Billion By 2030 With A 12.3% CAGR
The cell and gene therapy contract research organization market has experienced significant expansion recently. This market is projected to expand from $6.92 billion in 2025 to $7.76 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.1%. Historically, this growth has been driven by several factors, including a rise in early-stage cell and gene therapy initiatives, insufficient internal development capacities, expanding research pipelines for rare diseases, the increasing intricacy of regulatory requirements for advanced therapies, and a greater dependence on outside research proficiency.
The cell and gene therapy contract research organization market is projected for significant expansion over the coming years, with its size forecast to reach $12.36 billion by 2030, showing a compound annual growth rate (CAGR) of 12.3%. This expansion during the projection period is primarily driven by factors such as an uptick in clinical trial activities for gene therapies, the broadening scope of personalized medicine development, increased funding directed towards research in oncology and genetic disorders, a growing need for faster development timelines, and enhanced partnerships between biotechnology companies and CROs. Key developments anticipated in this period include a rise in outsourcing of cell and gene therapy research, increased demand for combined preclinical and clinical services, an intensified focus on regulatory and compliance proficiency, expanded support for vector development and manufacturing, and greater utilization of data-driven approaches in trial management.
Get A Free Sample Report With In-Depth Market Insights:
Cell And Gene Therapy Contract Research Organization Market Growth Drivers: What’s Behind The Acceleration?
The growing emphasis on personalized medicine and targeted therapeutics is projected to stimulate the expansion of the cell and gene therapy contract research organization (CRO) market moving forward. Personalized medicine and targeted therapeutics involve crafting treatments specifically adapted to an individual’s genetic, molecular, or cellular attributes to boost effectiveness and lessen adverse reactions. This increased focus on personalized medicine stems from regulators and healthcare systems prioritizing precision-based therapies to tackle complex illnesses and achieve greater clinical success rates. Cell and gene therapy contract research organizations (CROs) play a crucial role in supporting personalized medicine by delivering specialized preclinical, clinical, and regulatory services necessary for the development, testing, and validation of intricate gene- and cell-based therapeutic products. For instance, in April 2025, the Food and Drug Administration (FDA) approved 18 personalized medicines in 2024, representing approximately 38% of all newly approved therapeutic molecular entities, according to the Personalized Medicine Coalition, a US-based nonprofit organization. Consequently, the intensified focus on personalized medicine and targeted therapeutics is propelling the growth of the cell and gene therapy contract research organization (CRO) market.
Cell And Gene Therapy Contract Research Organization Market Segment Trends And Revenue Contributors
The cell and gene therapy contract research organization market covered in this report is segmented –
1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types
2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services
3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications
4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies
5) By Application: Hospital; Research Institute; Other Applications
Subsegments:
1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services
2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services
3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services
Cell And Gene Therapy Contract Research Organization Market Trends: What’s Defining The Industry’s Next Phase?
Key players within the cell and gene therapy contract research organization (CRO) market are concentrating on evolving new solutions, like extended laboratory and analytical services, to boost the efficiency of therapy development, ensure adherence to regulations, and refine research accuracy. This is achieved by offering cutting-edge facilities, dedicated equipment, and cohesive cell and gene therapy testing competencies. These extended services signify contract research organization (CRO) provisions designed to augment capacity, facilitate the execution of intricate assays, and assist sponsors from inception to completion in the creation of advanced cell and gene therapies. A notable example occurred in August 2025, when Labcorp Holdings Inc., a US-based healthcare company, enlarged its cell and gene therapy laboratory in Madison, Wisconsin, thereby strengthening its expertise in cell characterization, vector analytics, and testing that adheres to regulatory standards. This augmented facility now provides specialized infrastructure for complex cell and gene therapy processes, supports the rapid processing of numerous samples, and incorporates sophisticated analytical platforms, establishing itself as a complete solution for expediting cell and gene therapy research and development.
Cell And Gene Therapy Contract Research Organization Market Key Players Shaping Industry Direction
Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC
View The Full Cell And Gene Therapy Contract Research Organization Market Report:
Cell And Gene Therapy Contract Research Organization Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model